Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HS-10506 in Chinese Adult Patients With Insomnia Disorder
NCT07677384Phase 3Not yet recruiting
- Sponsor
- Hansoh Pharmaceutical Group
- Start
- Jun 2026
- Primary completion
- Jun 2029
01
Overview
A Phase 3 trial of HS-10506 in insomnia disorder, sponsored by Hansoh Pharmaceutical Group. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
HS-10506
03
Conditions
insomnia disorder
Beyond the preview
Go deeper on NCT07677384.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07677384.